Company Data
Astria Therapeutics Inc.
Ticker
ATXS
Current Price
$7.06 0.57%
Market Cap
$398.4M
Price Target
Refer to Report
Volume
204.5K
52wk Range
$6.64 - $16.9
Overview
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.